<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03618875</url>
  </required_header>
  <id_info>
    <org_study_id>icepreventpain</org_study_id>
    <nct_id>NCT03618875</nct_id>
  </id_info>
  <brief_title>Reduction of Post Intravitreal Injection Bleeding and Pain by Ice</brief_title>
  <official_title>Reduction of Post Intravitreal Injection Bleeding and Pain by Ice</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wolfson Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wolfson Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intravitreal injections are an efficient method for delivering intraocular therapeutic agents
      in numerous ophthalmologic diseases. However, side effects, such as pain and subconjunctival
      hemorrhage remain a major concern.

      Prevention or alleviation of those side effects might shorten the healing duration and
      improve patients' quality of life.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      cooling the eye using ice patched prior to Intravitreal injections may ameliorated pain and
      subconjunctival hemorrhage incidences.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Actual">November 25, 2017</completion_date>
  <primary_completion_date type="Actual">November 1, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain</measure>
    <time_frame>change between VAS pain score at baseline and 10 minutes</time_frame>
    <description>Visual Analogue Scale (VAS) is a Likert-type scale (1-10). The VAS is a reliable tool in evaluating and quantifying ocular discomfort</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>size of subconjunctival hemorrhage</measure>
    <time_frame>change between subconjunctival hemorrhage at baseline and 10 minutes</time_frame>
    <description>subconjunctival hemorrhage in mm</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>ice</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients were randomly assigned to receive an ice 5 minutes prior the IViT</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients were randomly assigned to a room temperature patch (placebo) 5 minutes prior the IViT</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ice pack</intervention_name>
    <description>ice pack was placed on eyelid 5 minutes prior to IVIT</description>
    <arm_group_label>ice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>room temperature pack</intervention_name>
    <description>room temperature pack was placed on eyelid 5 minutes prior to IVIT</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        patients receiving intravitreal injection

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The E.Wolfson Medical Center</name>
      <address>
        <city>Holon</city>
        <zip>58100</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <study_first_submitted>November 26, 2017</study_first_submitted>
  <study_first_submitted_qc>August 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 7, 2018</study_first_posted>
  <last_update_submitted>August 5, 2018</last_update_submitted>
  <last_update_submitted_qc>August 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>no plan</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

